Iterum Therapeutics plc (ITRM)

Iterum Therapeutics Analyst Ratings

• Total Analysts: 1
• Consensus Rating: Strong Buy
• Price Target: $6.00
• Upside: +287.10%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+287.10%	Apr 1, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+287.10%	Mar 6, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $6	Hold → Strong Buy	Upgrades	$6	+287.10%	Feb 7, 2024
Kevin Kedra Gabelli & Co.	Gabelli & Co.	Strong Sell → Hold Upgrades n/a	Strong Sell → Hold	Upgrades	n/a	n/a	Jul 27, 2021
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 26, 2021
Kevin Kedra Gabelli & Co.	Gabelli & Co.	Strong Sell → Hold Upgrades n/a	Strong Sell → Hold	Upgrades	n/a	n/a	May 28, 2021
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades n/a	Hold → Strong Buy	Upgrades	n/a	n/a	Mar 15, 2021
Ami Fadia SVB Leerink	SVB Leerink	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Oct 1, 2020
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jun 16, 2020
Gregory Renza RBC Capital	RBC Capital	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Dec 11, 2019
Ami Fadia SVB Leerink	SVB Leerink	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Dec 11, 2019
Adnan Butt Guggenheim	Guggenheim	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Jun 19, 2018
Alan Carr Needham	Needham	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Jun 19, 2018
Ami Fadia Leerink Swann	Leerink Swann	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Jun 19, 2018